(a and b) Illustrations of pericyte containing microvascular networks in the spiral ganglion region. (A) A confocal projection image of the spiral lamina from an NG2DsRedBAC mouse shows pericytes …
(A) Schematic of a pericyte-depletion mouse model incorporating an inducible Cre-loxP system. (B) The diagram shows the timeline of tamoxifen and diphtheria toxin (DT) administration and the time …
(A) The control mice showed no significant hearing threshold change after diphtheria toxin (DT) injection (n=10, p=0.9651). In contrast, the hearing threshold in pericyte-depleted animals was …
(A) Representative confocal images from control and pericyte-depleted animals, labeled with antibody for β-III tubulin. (B) Significant SGN loss at all turns 2 wk after diphtheria toxin (DT) …
(A) The 20 most significant overrepresented PANTHER pathways for genes (RPKM>0.5) identified in cochlear pericytes. (B) Neonatal spiral ganglion neuron (SGN) explants co-cultured with pericytes show …
(A) Schematic of the exosome purification procedure used to isolate exosomes from pericyte-conditioned culture medium for nanoparticle tracking analysis (NTA), transmission electron microscopy …
Protein families of cochlear pericyte-derived exosomes identified by proteomics analysis.
(A) mRNA expression of VEGF-A in primary cochlear pericytes. (B) VEGF-A production assessed by ELISA at day 3 in the control and pericyte containing culture medium (n=6, p<0.0001, unpaired t test). …
Original uncropped blots of VEGFA and PDGFR-β, and raw gel data of whole protein staining with the relevant bands clearly labeled.
Original uncropped blots of VEGFA and PDGFR-β, and raw gel data of whole protein staining with the relevant bands clearly labeled.
(A–C) Representative confocal images of a cochlear whole mount under low (A) and high (B and C) magnification. (D) Cross section showing VEGFR2 (red) is positively expressed in both spiral ganglion …
(A) Exosomes were purified from pericyte-conditioned media using total exosome isolation reagent for in vitro treatment. (B) Compared to the control group, exosome treated SGN explants showed robust …
(A) Representative images showing the pattern of SGN dendritic growth under different experimental conditions. (B and C) Number and length of dendritic fibers when the VEGFR2 receptor is blocked. A …
(A) Under normal conditions, pericytes participate in the maintenance of SGN health through two parallel pathways: (1) One maintains vascular stability and function and (2) the other ‘nourishes’ …
(A and B) The cochlear middle turns were dissected out, stria vascularis and organ of Corti discarded, and the remaining SGN cut into three 90° fan-shaped pieces. These were attached to a coated …
Two major microvascular networks in the cochlea include the network in the cochlear lateral wall and network in the region of spiral ganglion neurons (SGNs)-blood vessels penetrate the SGNs and …
No. | PANTHER pathways | % of gene in the list | −Log10 (FDR (false discovery rate)) | |
---|---|---|---|---|
Mus musculus (REF) | Pericyte | |||
1 | Inflammation mediated by chemokine and cytokine signaling pathway | 1.181979 | 5.072464 | 14.88941 |
2 | CCKR signaling map | 0.74101 | 3.804348 | 13.30277 |
3 | Angiogenesis | 0.813747 | 3.713768 | 11.61261 |
4 | Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | 0.554621 | 2.717391 | 8.9914 |
5 | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | 0.722826 | 2.98913 | 8.364516 |
6 | Wnt signaling pathway | 1.418375 | 4.257246 | 8.073658 |
7 | Gonadotropin-releasing hormone receptor pathway | 1.068327 | 3.623188 | 8.066513 |
8 | T cell activation | 0.409147 | 2.173913 | 7.876148 |
9 | Apoptosis signaling pathway | 0.563713 | 2.445652 | 7.314258 |
10 | Endothelin signaling pathway | 0.377324 | 1.992754 | 7.218245 |
11 | B cell activation | 0.322771 | 1.811594 | 6.931814 |
12 | VEGF signaling pathway | 0.304587 | 1.630435 | 5.958607 |
13 | Oxytocin receptor mediated signaling pathway | 0.272764 | 1.449275 | 5.242604 |
14 | Histamine H1 receptor mediated signaling pathway | 0.209119 | 1.268116 | 5.136677 |
15 | PI3 kinase pathway | 0.245488 | 1.358696 | 5.135489 |
16 | Thyrotropin-releasing hormone receptor signaling pathway | 0.286403 | 1.449275 | 5.086716 |
17 | Alzheimer disease-presenilin pathway | 0.577351 | 1.992754 | 4.640165 |
18 | Integrin signaling pathway | 0.863754 | 2.445652 | 4.315155 |
19 | Alzheimer disease-amyloid secretase pathway | 0.300041 | 1.358696 | 4.308919 |
20 | 5HT2 type receptor mediated signaling pathway | 0.309133 | 1.358696 | 4.194499 |
21 | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | 0.272764 | 1.268116 | 4.154902 |
22 | PDGF signaling pathway | 0.650089 | 1.992754 | 4.017277 |
23 | Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction | 0.177297 | 0.996377 | 3.886057 |
24 | EGF receptor signaling pathway | 0.618266 | 1.902174 | 3.882729 |
25 | Interleukin signaling pathway | 0.395508 | 1.449275 | 3.721246 |
26 | Muscarinic acetylcholine receptor 2 and 4 signaling pathway | 0.272764 | 1.177536 | 3.636388 |
27 | FGF signaling pathway | 0.554621 | 1.721014 | 3.603801 |
28 | Cytoskeletal regulation by Rho GTPase | 0.363686 | 1.358696 | 3.595166 |
29 | Nicotinic acetylcholine receptor signaling pathway | 0.450061 | 1.449275 | 3.19382 |
30 | p53 pathway feedback loops 2 | 0.227304 | 0.996377 | 3.157391 |
31 | ATP synthesis | 0.031823 | 0.452899 | 3.123782 |
32 | Axon guidance mediated by netrin | 0.159113 | 0.815217 | 3.010105 |
33 | Beta1 adrenergic receptor signaling pathway | 0.209119 | 0.905797 | 2.886057 |
34 | Enkephalin release | 0.168205 | 0.815217 | 2.882729 |
35 | GABA-B receptor II signaling | 0.168205 | 0.815217 | 2.869666 |
36 | Metabotropic glutamate receptor group II pathway | 0.213665 | 0.905797 | 2.832683 |
37 | Insulin/IGF pathway-protein kinase B signaling cascade | 0.177297 | 0.815217 | 2.772113 |
38 | Blood coagulation | 0.236396 | 0.905797 | 2.551294 |
39 | FAS signaling pathway | 0.154567 | 0.724638 | 2.522879 |
40 | Nicotine pharmacodynamics pathway | 0.159113 | 0.724638 | 2.462181 |
41 | Dopamine receptor mediated signaling pathway | 0.25458 | 0.905797 | 2.376751 |
42 | Beta2 adrenergic receptor signaling pathway | 0.209119 | 0.815217 | 2.366532 |
43 | Alpha adrenergic receptor signaling pathway | 0.10456 | 0.543478 | 2.095284 |
44 | Axon guidance mediated by Slit/Robo | 0.113652 | 0.543478 | 1.978811 |
45 | TGF-beta signaling pathway | 0.459154 | 1.177536 | 1.978811 |
46 | p53 pathway | 0.400055 | 1.086957 | 1.974694 |
47 | Androgen/estrogene/progesterone biosynthesis | 0.077283 | 0.452899 | 1.970616 |
48 | Endogenous cannabinoid signaling | 0.113652 | 0.543478 | 1.970616 |
49 | Cortocotropin releasing factor receptor signaling pathway | 0.154567 | 0.634058 | 1.970616 |
50 | Histamine H2 receptor mediated signaling pathway | 0.118198 | 0.543478 | 1.931814 |
51 | 5HT1 type receptor mediated signaling pathway | 0.209119 | 0.724638 | 1.910095 |
52 | Opioid proopiomelanocortin pathway | 0.168205 | 0.634058 | 1.853872 |
53 | Hypoxia response via HIF activation | 0.12729 | 0.543478 | 1.821023 |
54 | TCA cycle | 0.054553 | 0.362319 | 1.754487 |
55 | Cadherin signaling pathway | 0.736464 | 1.539855 | 1.686133 |
56 | Pyruvate metabolism | 0.059099 | 0.362319 | 1.669586 |
57 | Triacylglycerol metabolism | 0.009092 | 0.181159 | 1.446117 |
58 | Opioid prodynorphin pathway | 0.163659 | 0.543478 | 1.407823 |
59 | Opioid proenkephalin pathway | 0.172751 | 0.543478 | 1.321482 |
Gene list of cochlear pericytes identified by RNA-seq analysis.
Protein | Gene names | # PSMs | Log2 LFQ (label-free quantitation) intensity |
---|---|---|---|
CD81 antigen | Cd81 | 26 | 29.6153 |
CD63 antigen | Cd63 | 3 | 26.1908 |
CD9 antigen | Cd9 | 16 | 29.2576 |
Tumor susceptibility gene 101 | Tsg101 | 5 | 25.7598 |
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus) | C57BL/6J | The Jackson Laboratory | RRID:IMSR_JAX:000664 | |
Strain, strain background (M. musculus) | B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J | The Jackson Laboratory | RRID:IMSR_JAX:007909 | |
Strain, strain background (M. musculus) | B6.Cg-Tg(Pdgfrb-cre/ERT2)6096Rha/J | The Jackson Laboratory | RRID:IMSR_JAX:029684 | |
Strain, strain background (M. musculus) | C57BL/6-Gt(ROSA)26Sortm1(HBEGF)Awai/J | The Jackson Laboratory | RRID:IMSR_JAX:007900 | |
Strain, strain background (M. musculus) | Tg(Cspg4-DsRed.T1)1Akik/J | The Jackson Laboratory | RRID:IMSR_JAX:008241 | |
Antibody | anti-Desmin [Y66] (Rabbit monoclonal) | Abcam | Cat#: ab32362 | 1:50 |
Antibody | anti-β-III Tubulin [EP1569Y] (Rabbit monoclonal) | Abcam | Cat#: ab52623 | 1:200 |
Antibody | anti-CD31 [MEC 7.46] (Rat monoclonal) | Abcam | Cat#: ab7388 | 1:100 |
Antibody | anti-VEGFR2 [EPR21884-236] (Rabbit monoclonal) | Abcam | Cat#: ab233693 | 1:500 |
Antibody | anti-VEGFA (Rabbit polyclonal) | Abcam | Cat#: ab51745 | 1:400 |
Antibody | anti-PDGFRβ [Y92] (Rabbit monoclonal) | Abcam | Cat#: ab32570 | 1:1000-1:5000 |
Sequence-based reagent | B6.Cg-Tg(Pdgfrb-cre/ERT2)6096Rha/J F | The Jackson Laboratory | PCR primers | GAA CTG TCA CCG GGA GGA |
Sequence-based reagent | B6.Cg-Tg(Pdgfrb-cre/ERT2)6096Rha/J R | The Jackson Laboratory | PCR primers | AGG CAA ATT TTG GTG TAC GG |
Sequence-based reagent | B6.Cg-Tg(Pdgfrb-cre/ERT2)6096Rha/J internal positive control F | The Jackson Laboratory | PCR primers | CAA ATG TTG CTT GTC TGG TG |
Sequence-based reagent | B6.Cg-Tg(Pdgfrb-cre/ERT2)6096Rha/J internal positive control R | The Jackson Laboratory | PCR primers | GTC AGT CGA GTG CAC AGT TT |
Sequence-based reagent | Mouse VEGFA F | IDT | PCR primers | GCAGCGACAAGGCAGACTA |
Sequence-based reagent | Mouse VEGFA R | IDT | PCR primers | GGTCCGATGCAAGATCCCAA |
Peptide, recombinant protein | Diphtheria toxin | Sigma | Cat#: D0564 | 10 ng/g body weight |
Peptide, recombinant protein | Dispase II | Sigma | Cat#: D4693 | |
Peptide, recombinant protein | Collagenase I | ThermoFisher | Cat#: 17018029 | |
Peptide, recombinant protein | DNase I | Sigma | Cat#: 10104159001 | |
Peptide, recombinant protein | 100× Penicillin-Streptomycin Solution | Invitrogen/Gibco | Cat#: 15140–122 | |
Commercial assay or kit | Invitrogen Total Exosome Isolation Reagent (from cell culture media) | ThermoFisher | Cat#: 4478359 | |
Commercial assay or kit | SuperSignal West Femto Duration Substrate | Thermo Fisher Scientific | Cat#: A38554 | |
Commercial assay or kit | Clontech SMARTer cDNA kit | Clontech Laboratories | Cat#: 634925 | |
Commercial assay or kit | NEBNext reagents | New England Biolabs | Cat#: E6040 | |
Commercial assay or kit | RNeasy micro kit | Qiagen | Cat#: 74004 | |
Commercial assay or kit | SuperScript IV First-Strand Synthesis kit | ThermoFisher | Cat#: 18091050 | |
Commercial assay or kit | VEGFA ELISA Kit | Abcam | Cat#: ab119565 | |
Commercial assay or kit | BCA protein assay kit | Abcam | Cat#: ab102536 | |
Commercial assay or kit | ExoGlow-Protein EV Labeling Kit (Green) | SBI | Cat#: EXOGP300A-1 | |
Chemical compound and drug | Tamoxifen | Sigma | Cat#: T5648 | 75 mg/kg body weight |
Chemical compound and drug | SU5408 | Abcam | Cat#: ab145888 | |
Software and algorithm | Sample Size Calculator | N/A | https://clincalc.com/stats/samplesize.aspx | |
Software and algorithm | ImageJ | NIH | https://imagej.nih.gov/ij/ | |
Software and algorithm | PANTHER classification system | N/A | http://www.pantherdb.org/ | |
Software and algorithm | REVIGO | Ruđer Bošković Institute | http://revigo.irb.hr/ | |
Other | Lectin-DyLight 488 | Vector Laboratories | Cat#: DL-1174 | 20 μg/ml |
Other | Lectin-DyLight 649 | Vector Laboratories | Cat#: DL-1178 | 20 μg/ml |
Other | Decal Stat Decalcifier | StatLab | Cat#: 1212–32 | Use directly (contains Hydrogen Chloride, Acid mists, strong inorganic) |
Other | Antifade Mounting Medium with DAPI | Vector Laboratories | Cat#: H-1200 | Use directly (contains 1 μg/ml of DAPI) |